Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1682402

registered interest
date	16/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Anniversaries
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she is taking steps to celebrate the 75th anniversary of the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	9832
answer	answer is ministerial correction date of answer 18/01/2024 answer text <p>2023 marked the 75th anniversary of the National Health Service. To mark the occasion, over the course of June and July 2023, the Department and NHS England made several flagship announcements. These included: the NHS Long Term Workforce Plan; a new national targeted lung cancer screening programme; the Government’s Mandate to NHS England; an additional one million health checks to tackle cardiovascular disease through the new NHS Digital Health Checks; and a £21 million fund for NHS trusts to bid and procure artificial intelligence diagnostic imaging tools.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 18/01/2024 15:00:26 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4131 label Biography information for Jim Shannon

1681910

registered interest
date	15/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Construction
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether her Department has made an assessment of the potential impact of the Hospitals Transformation Programme on the number of beds available for patients.
tabling member constituency	Shrewsbury and Atcham
tabling member printed	Daniel Kawczynski
uin	9477
answer	answer is ministerial correction date of answer 18/01/2024 answer text <p>Expected capacity requirements and patient need was modelled and outlined in the recent Outline Business Case (OBC) for the Hospitals Transformation Programme in Shropshire. The OBC was reviewed and approved by the Department of Health and Social Care, NHS England, and HM Treasury in December 2023. The full business case is expected in the coming months.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 18/01/2024 11:55:23 answering member 4044 label Biography information for Andrew Stephenson
tabling member	1566 label Biography information for Daniel Kawczynski

1681978

registered interest
date	15/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many applications for research grant funds for studies into lobular breast cancer have been submitted to the National Institute for Health and Care Research in the last 24 months.
tabling member constituency	Brentford and Isleworth
tabling member printed	Ruth Cadbury
uin	9526
answer	answer is ministerial correction date of answer 18/01/2024 answer text <p>The Department invests in health research through the National Institute for Health and Care Research (NIHR). NIHR invests in research, clinical expertise, specialist facilities, workforce and support services across a range of clinical areas. NIHR expenditure on cancer research was £121.8 million in 2022/23.</p><p>The Department and NIHR are aware of lobular breast cancer and issues in detection and treatment. Lobular breast cancers can be hard to detect through screening. Relevant research includes a £1.3 million NIHR research project to determine whether an abbreviated form of breast magnetic resonance imaging can detect breast cancers missed by screening mammography.<em> </em>We would urge researchers working on lobular breast cancer to submit research bids for NIHR funding, including applications to fund the United Kingdom arm of international studies. Details on eligibility and how to apply for Departmental research funding through the NIHR is available and updated on the NIHR website.</p><p>Since 2021/22, there have been five research grant bids for NIHR funding into lobular breast cancer. The above project was a successful research bid, while there were four unsuccessful applications judged by a scientific panel of peers during the same period. NIHR also supports research on lobular breast cancer through its research infrastructure including Biomedical Research Centres (BRCs). Researchers at NIHR Manchester BRC have shown that women at increased risk of breast cancer who were offered enhanced screening were more likely to survive in the long-term. In addition, NIHR supports breast cancer research funded by research partners in the charity and public sectors through the NIHR’s Clinical Research Network (CRN). Over the last five years the CRN has supported 10 lobular breast cancer-related studies.</p><p>The NIHR welcomes funding applications for research into any aspect of human health, including lobular breast cancer. The Department also continues to work closely with research funding partners such as Cancer Research UK and cancer charities, who fund research into new scientific discoveries.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 9705 question first answered 18/01/2024 12:06:57 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4389 label Biography information for Ruth Cadbury

1681979

registered interest
date	15/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Kidney Diseases: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people are undergoing dialysis treatment in Easington constituency.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	9497
answer	answer is ministerial correction date of answer 18/01/2024 answer text <p>Data on dialysis that takes place at home is not collected centrally. The following table shows dialysis in English National Health Service hospitals as well as English NHS-commissioned activity in the independent sector for patients resident in the Easington constituency:</p><table><tbody><tr><td><p>Year</p></td><td><p>Episodes</p></td><td><p>Patients</p></td></tr><tr><td><p>2018/19</p></td><td><p>210</p></td><td><p>50</p></td></tr><tr><td><p>2019/20</p></td><td><p>225</p></td><td><p>40</p></td></tr><tr><td><p>2020/21</p></td><td><p>225</p></td><td><p>45</p></td></tr><tr><td><p>2021/22</p></td><td><p>140</p></td><td><p>55</p></td></tr><tr><td><p>2022/23</p></td><td><p>215</p></td><td><p>50</p></td></tr></tbody></table><p>Source: Hospital Episode Statistics, NHS England</p><p> </p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 18/01/2024 15:36:55 answering member 4044 label Biography information for Andrew Stephenson
tabling member	3973 label Biography information for Grahame Morris

1682068

registered interest
date	15/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ivacaftor/tezacaftor/elexacaftor
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent discussions she has had with (a) NICE and (b) pharmaceutical companies on the affordability of Kaftrio.
tabling member constituency	Stockport
tabling member printed	Navendu Mishra
uin	9687
answer	answer is ministerial correction date of answer 18/01/2024 answer text <p>Departmental officials regularly discuss a range of issues with colleagues in the National Institute for Health and Care Excellence (NICE), including in relation to the development of guidance on individual products. The Department has had no recent discussions with Vertex.</p><p>NICE is an independent body, and its recommendations are developed in accordance with its published methods and processes. NICE is currently developing guidance for the National Health Service on whether Kaftrio, and other cystic fibrosis medicines, represents a clinically and cost effective use of NHS resources and recently consulted on its draft recommendations. Kaftrio is currently available as a treatment option for eligible NHS patients under the terms of an interim access agreement, which was originally reached in 2019.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 18/01/2024 12:03:37 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4811 label Biography information for Navendu Mishra

1682182

registered interest
date	15/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will provide £20 million of funding for research for the Lobular Moon Shot Project.
tabling member constituency	Ynys Môn
tabling member printed	Virginia Crosbie
uin	9705
answer	answer is ministerial correction date of answer 18/01/2024 answer text <p>The Department invests in health research through the National Institute for Health and Care Research (NIHR). NIHR invests in research, clinical expertise, specialist facilities, workforce and support services across a range of clinical areas. NIHR expenditure on cancer research was £121.8 million in 2022/23.</p><p>The Department and NIHR are aware of lobular breast cancer and issues in detection and treatment. Lobular breast cancers can be hard to detect through screening. Relevant research includes a £1.3 million NIHR research project to determine whether an abbreviated form of breast magnetic resonance imaging can detect breast cancers missed by screening mammography.<em> </em>We would urge researchers working on lobular breast cancer to submit research bids for NIHR funding, including applications to fund the United Kingdom arm of international studies. Details on eligibility and how to apply for Departmental research funding through the NIHR is available and updated on the NIHR website.</p><p>Since 2021/22, there have been five research grant bids for NIHR funding into lobular breast cancer. The above project was a successful research bid, while there were four unsuccessful applications judged by a scientific panel of peers during the same period. NIHR also supports research on lobular breast cancer through its research infrastructure including Biomedical Research Centres (BRCs). Researchers at NIHR Manchester BRC have shown that women at increased risk of breast cancer who were offered enhanced screening were more likely to survive in the long-term. In addition, NIHR supports breast cancer research funded by research partners in the charity and public sectors through the NIHR’s Clinical Research Network (CRN). Over the last five years the CRN has supported 10 lobular breast cancer-related studies.</p><p>The NIHR welcomes funding applications for research into any aspect of human health, including lobular breast cancer. The Department also continues to work closely with research funding partners such as Cancer Research UK and cancer charities, who fund research into new scientific discoveries.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 9526 question first answered 18/01/2024 12:06:57 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4859 label Biography information for Virginia Crosbie

1681815

registered interest
date	12/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescription Drugs: Internet
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking with Cabinet colleagues to help tackle the sale of prescription-only drugs to patients without a prescription through illicit websites.
tabling member constituency	Hornsey and Wood Green
tabling member printed	Catherine West
uin	9352
answer	answer is ministerial correction date of answer 18/01/2024 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) is the regulator in the United Kingdom for human medicines and is responsible for enforcing the Human Medicines Regulations 2012. The MHRA has identified the illegal sale and supply of human medicines as a global challenge. This includes the sale of prescription drugs from unregulated sources. Criminal gangs, often based overseas, advertise medicines through illicit websites resembling those of legitimate pharmacies, while others exploit online marketplaces or sell social media platforms.</p><p>The MHRA has a dedicated Criminal Enforcement Unit (CEU) that works with partners across government and policing to prevent and disrupt this illegal trade and to bring to justice those involved. The CEU monitors online channels for evidence of illegal activity and takes proportionate regulatory action. This includes using the full range of the Agency’s powers to investigate and prosecute offenders where necessary and appropriate. The unit also works to remove illegally trading websites and remove criminal profits from offenders. Through its #Fakemeds communications campaign the MHRA also provides quick and easy tools to help the public avoid buying illegally traded medicines when they shop online.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 18/01/2024 11:53:22 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4523 label Biography information for Catherine West

1681526

registered interest
date	11/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Physician Associates: Regulation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when she plans to bring forward legislative proposals to regulate the physician associate role.
tabling member constituency	Slough
tabling member printed	Mr Tanmanjeet Singh Dhesi
uin	9266
answer	answer is ministerial correction date of answer 18/01/2024 answer text <p>On 13 December 2023, the Department laid draft legislation in both Houses and in the Scottish Parliament that will empower the General Medical Council (GMC) to regulate physician associates and anaesthesia associates.</p><p>Subject to parliamentary scrutiny, this legislation will instruct the GMC to commence regulation. The GMC will then have to consult on their own rules, policies and guidance and begin regulating these roles in or before December 2024.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 18/01/2024 12:43:57 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi

1681617

registered interest
date	11/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will make a comparative assessment of the adequacy of funding her Department provides to help tackle (a) less survivable cancers compared to (b) other cancers; and if she will make it her policy to (i) create a framework assessing the challenges around cancers with lower survival rates and (ii) increase funding for those cancers.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	9249
answer	answer is ministerial correction date of answer 18/01/2024 answer text <p>The Government is taking steps through NHS England to improve outcomes for cancer patients, including those with less survivable cancers. Making improvements across different cancer types is critical to helping achieve the NHS Long Term Plan ambition of diagnosing 75% of patients at an early stage by 2028 and reducing inequalities in cancer survival. NHS England has commissioned new cancer clinical audits covering five cancer types, some of which are less survivable: pancreatic cancer, ovarian cancer, non-Hodgkin lymphoma, kidney cancer and primary and metastatic breast cancer. All five audits will cover care delivered in England and Wales and will see an investment of approximately £5.4 million for an initial period of three years.</p><p>NHS England is responsible for funding allocations to integrated care boards (ICBs). ICBs then decide how that money is spent within the local integrated care system. The allocations process is independent of Government and NHS England takes advice on the underlying formula from the independent Advisory Committee on Resource Allocation. NHS England produces a target allocation, or 'fair share' for each area, based on a complex assessment of factors such as demography, morbidity, deprivation, and the unavoidable cost of providing services in different areas. This means that funding decisions are fair and equitable.</p><p>Delivering more research is key to understanding and assessing the challenges around cancers with lower survival rates. As with other Government funders of health research, the National Institute for Health and Care Research (NIHR) does not allocate funding for specific disease areas, including less survivable cancers. The level of research spend in a particular area is driven by factors including scientific potential and the number and scale of successful funding applications. The NIHR welcomes funding applications for research into any aspect of human health, including less survivable cancers.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 18/01/2024 11:43:20 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4471 label Biography information for Rachael Maskell

1680738

registered interest
date	09/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the Government is on track to meet its funding targets for the dementia moonshot.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	8758
answer	answer is ministerial correction date of answer 18/01/2024 answer text <p>The Government is strongly committed to supporting research into dementia and has committed to double funding for dementia research. We will double funding for dementia research to £160 million per year by the end of 2024/25. We estimate that the Government spent over £454 million on dementia research from 2018/19 to 2022/23.</p><p>On 14 August 2022, the former Prime Minister launched the Dame Barbara Windsor Dementia Mission, along with £95 million of funding. The Mission is part of the commitment to double dementia research funding and aims to develop innovative research tools and boost the number and speed of clinical trials in dementia and neurodegeneration. In the Autumn Statement 2023, the Government stated it is launching the first Clinical Trials Delivery Accelerator focused on dementia, with up to £20 million of funding to help innovation reach National Health Service patients even faster.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 18/01/2024 14:26:20 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4471 label Biography information for Rachael Maskell